Compounded tirzepatide typically remains stable for 30 to 90 days when stored at 28C (refrigerated), though stability windows vary based on the specific compounding pharmacy's formulation, diluent used, and quality assurance protocols
Specifically, the company states that FDA-approved GLP-1/GIP medications for weight loss and type 2 diabetes, including Ozempic, Wegovy, Zepbound, and Mounjaro, "may also be eligible for coverage." The company further states that while they "assist with prior authorizations and prescription submissions," they "do not bill insurance directly." This distinction is important: the compounded GLP-1 program itself is described as a cash-pay arrangement, but the company also facilitates access to FDA-approved branded medications that may have insurance pathways
Tirzepatide, administered via a once-weekly subcutaneous injection, is typically available in the following dosage options for the treatment of type 2 diabetes: What is the Research Dosage
In-house testing alone is less reliable